Department of Biochemistry, University of Minnesota, Minneapolis, MN 55455, USA.
Curr Top Microbiol Immunol. 2013;371:1-27. doi: 10.1007/978-3-642-37765-5_1.
The ability to regulate and even target mutagenesis is an extremely valuable cellular asset. Enzyme-catalyzed DNA cytosine deamination is a molecular strategy employed by vertebrates to promote antibody diversity and defend against foreign nucleic acids. Ten years ago, a family of cellular enzymes was first described with several proving capable of deaminating DNA and inhibiting HIV-1 replication. Ensuing studies on the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) restriction factors have uncovered a broad-spectrum innate defense network that suppresses the replication of numerous endogenous and exogenous DNA-based parasites. Although many viruses possess equally elaborate counter-defense mechanisms, the APOBEC3 enzymes offer a tantalizing possibility of leveraging innate immunity to fend off viral infection. Here, we focus on mechanisms of retroelement restriction by the APOBEC3 family of restriction enzymes, and we consider the therapeutic benefits, as well as the possible pathological consequences, of arming cells with active DNA deaminases.
调控甚至靶向突变的能力是细胞的一项极其宝贵的资产。酶催化的 DNA 胞嘧啶脱氨酶是脊椎动物用来促进抗体多样性和抵御外来核酸的一种分子策略。十年前,首次描述了一组具有几种能够使 DNA 脱氨酶和抑制 HIV-1 复制能力的细胞酶。随后对载脂蛋白 B mRNA 编辑酶催化多肽样 3(APOBEC3)限制因子的研究揭示了一个广谱的先天防御网络,该网络抑制了许多内源性和外源性基于 DNA 的寄生虫的复制。尽管许多病毒都具有同样精细的反防御机制,但 APOBEC3 酶提供了一种诱人的可能性,即利用先天免疫来抵御病毒感染。在这里,我们重点介绍 APOBEC3 家族限制酶对逆转录元件的限制机制,并考虑用具有活性 DNA 脱氨酶武装细胞的治疗益处以及可能的病理后果。